Blood Cancer

(asked on 9th October 2024) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information his Department holds on regional variations in (a) the speed of diagnosis and (b) health outcomes for blood cancer patients.


Answered by
Karin Smyth Portrait
Karin Smyth
Minister of State (Department of Health and Social Care)
This question was answered on 16th October 2024

We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out.

The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer.

Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.

Professor Lord Darzi has undertaken an independent investigation into the state of the NHS, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will therefore set out any further priorities on cancer and health in due course.

The National Disease Registration Service, through the National Cancer Registration and Analysis Services (NCRAS), collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The National Disease Registration Service’s website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:

https://www.cancerdata.nhs.uk/

All cases of cancer diagnosed and treated in the NHS in England are registered by the NCRAS. This creates a clinically rich data resource that is used to measure diagnosis, treatment, and outcomes for patients diagnosed with cancer. The data held by the NCRAS supports service provision and commissioning in the NHS, clinical audits, and public health and epidemiological research, all of which contribute to improved outcomes for those diagnosed with cancer.

Reticulating Splines